Skip to main content

Advertisement

ADVERTISEMENT

ISET 2023

Endograft Durability 30 Years Later; Results From the PROMISE II U.S. Pivotal Trial

Daniel Clair, MD

Vanderbilt University Medical Center, Nashville, Tennessee

In this video from ISET 2023, Dr. Daniel Clair from Vanderbilt University Medical Center in Nashville, Tennessee, discusses his presentations on endograft durability and results of the PROMISE II trial, which investigated the safety and effectiveness of the LimFlow System for creating an AV connection in the BTK vascular system using an endovascular, minimally invasive approach to arterialize the pedal veins for the treatment of CLTI.


Advertisement

Advertisement

Advertisement